Literature DB >> 16632429

Bronchiolitis obliterans organizing pneumonia simulating progression in bronchioloalveolar carcinoma.

Manuel Cobo Dols1, Silvia Gil Calle, Immaculada Alés Díaz, Ester Villar Chamorro, Julia Alcaide García, Vanesa Gutiérrez Calderón, Manuel Benavides Orgaz.   

Abstract

Bronchiolitis obliterans organizing pneumonia (BOOP) is a clinicopathologic syndrome with characteristic features. The diagnosis of BOOP requires the presence of a combination of pathological, clinical, and radiological features. We report the case of a lung cancer patient with bronquiloalveolar carcinoma (BAC) presenting with BOOP after chemotherapy with docetaxel and gemcitabine producing severe respiratory insufficiency, and simulating a progression of the tumor.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16632429     DOI： 10.1007/s12094-006-0171-0

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN： 1699-048X            Impact factor:   3.405


  10 in total

1.  Bronchiolitis obliterans organizing pneumonia syndrome in breast-conserving therapy for early breast cancer: radiation-induced lung toxicity.

Authors:  N Takigawa; Y Segawa; T Saeki; M Kataoka; M Ida; D Kishino; K Fujiwara; S Ohsumi; K Eguchi; S Takashima
Journal:  Int J Radiat Oncol Biol Phys       Date:  2000-10-01       Impact factor: 7.038

2.  [Bronchiolitis obliterans organizing pneumonia induced by chemotherapy].

Authors:  D Aguiar Bujanda; J Aguiar Morales; U Bohn Sarmiento
Journal:  Arch Bronconeumol       Date:  2004-06       Impact factor: 4.872

Review 3.  Bronchiolitis obliterans organizing pneumonia in cancer: a case series.

Authors:  M Mokhtari; P B Bach; P A Tietjen; D E Stover
Journal:  Respir Med       Date:  2002-04       Impact factor: 3.415

4.  Fatal pulmonary toxicity resulting from treatment with gemcitabine.

Authors:  N Pavlakis; D R Bell; M J Millward; J A Levi
Journal:  Cancer       Date:  1997-07-15       Impact factor: 6.860

Review 5.  Evolving concepts in the pathology and computed tomography imaging of lung adenocarcinoma and bronchioloalveolar carcinoma.

Authors:  William D Travis; Kavita Garg; Wilbur A Franklin; Ignacio I Wistuba; Bradley Sabloff; Masayuki Noguchi; Ryutaro Kakinuma; Maureen Zakowski; Michelle Ginsberg; Robert Padera; Francine Jacobson; Bruce E Johnson; Fred Hirsch; Elizabeth Brambilla; Douglas B Flieder; Kim R Geisinger; Frederik Thunnisen; Keith Kerr; David Yankelevitz; Teri J Franks; Jeffrey R Galvin; Douglas W Henderson; Andrew G Nicholson; Philip S Hasleton; Victor Roggli; Ming-Sound Tsao; Federico Cappuzzo; Madeline Vazquez
Journal:  J Clin Oncol       Date:  2005-05-10       Impact factor: 44.544

6.  Bronchiolitis obliterans organizing pneumonia in three children with acute leukaemias treated with cytosine arabinoside and anthracyclines.

Authors:  E Battistini; G Dini; C Savioli; A Morando; A Gandolfo; Z Kotitsa; A Garaventa; G A Rossi
Journal:  Eur Respir J       Date:  1997-05       Impact factor: 16.671

7.  Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer.

Authors:  Joan H Schiller; David Harrington; Chandra P Belani; Corey Langer; Alan Sandler; James Krook; Junming Zhu; David H Johnson
Journal:  N Engl J Med       Date:  2002-01-10       Impact factor: 91.245

8.  Topotecan-induced bronchiolitis.

Authors:  Colin C Edgerton; Matthew Gilman; Bernard J Roth
Journal:  South Med J       Date:  2004-07       Impact factor: 0.954

9.  Bronchiolitis obliterans organizing pneumonia.

Authors:  G R Epler; T V Colby; T C McLoud; C B Carrington; E A Gaensler
Journal:  N Engl J Med       Date:  1985-01-17       Impact factor: 91.245

Review 10.  Molecular predictors of response to chemotherapy in lung cancer.

Authors:  Rafael Rosell; Miquel Taron; Aurelio Ariza; Agusti Barnadas; Jose Luis Mate; Noemí Reguart; Mireia Margel; Enriqueta Felip; Pedro Méndez; Rosario García-Campelo
Journal:  Semin Oncol       Date:  2004-02       Impact factor: 4.929
  10 in total
  4 in total

1.  BOOP as a rare complication of gemcitabine therapy.

Authors:  Hameem I Kawsar; Timothy P Spiro; Amy Cocco; Hamed A Daw
Journal:  BMJ Case Rep       Date:  2011-07-20

2.  Severe Organizing Pneumonia after Two Cycles of Docetaxel as Fourth-Line Chemotherapy for Advanced Non-Small Cell Carcinoma of the Lung.

Authors:  Jens Hasskarl; Percy Schroettner; Andrea von den Berg; Anja Rueckert; Alex Frydrychowicz; Gian Kayser; Cornelius F Waller
Journal:  Case Rep Oncol       Date:  2009-02-16

3.  Pneumonitis and pulmonary fibrosis in a patient receiving adjuvant docetaxel and cyclophosphamide for stage 3 breast cancer: a case report and literature review.

Authors:  Roberto Ochoa; Pablo A Bejarano; Stefan Glück; Alberto J Montero
Journal:  J Med Case Rep       Date:  2012-11-30

4.  Organizing pneumonia after pancreatic cancer treatment with nab-paclitaxel and gemcitabine: a case report.

Authors:  Francesca Comito; Elisa Grassi; Antonio Poerio; Eva Freier; Lucia Calculli; Maurizio Zompatori; Claudio Ricci; Riccardo Casadei; Mariacristina Di Marco
Journal:  BJR Case Rep       Date:  2018-02-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.